UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 22, 2012

 

 

Health Management Associates, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-11141   61-0963645

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

5811 Pelican Bay Boulevard, Suite 500, Naples, Florida   34108-2710
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (239) 598-3131

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders held on May 22, 2012, the stockholders of Health Management Associates, Inc. (the “Company”) voted on the matters described below.

 

  1. Stockholders elected nine directors, which constitute the Company’s entire Board of Directors. The table below summarizes the number of shares that: (i) voted for the election of each director; (ii) withheld authority to vote for each director; and (iii) represent broker non-votes with respect to each director.

 

Director Nominee

   Votes For      Votes Withheld      Broker
Non-Votes*
 

William J. Schoen

     197,155,645         8,096,689         19,163,759   

Gary D. Newsome

     197,509,989         7,742,345         19,163,759   

Kent P. Dauten

     193,513,831         11,738,503         19,163,759   

Pascal J. Goldschmidt, M.D.

     197,615,130         7,637,204         19,163,759   

Donald E. Kiernan

     197,241,290         8,011,044         19,163,759   

Robert A. Knox

     193,865,133         11,387,201         19,163,759   

Vicki A. O’Meara

     198,133,991         7,118,343         19,163,759   

William C. Steere, Jr.

     198,114,878         7,137,456         19,163,759   

Randolph W. Westerfield, Ph.D.

     197,331,188         7,921,146         19,163,759   

 

  2. On an advisory basis, stockholders approved the compensation of the Company’s named executive officers as such information is disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 9, 2012, including the Compensation Discussion and Analysis, compensation tables and other narrative disclosures included therein. The table below summarizes the number of shares that voted for, against and abstained from voting on the compensation of the Company’s named executive officers, as well as the number of shares representing broker non-votes with respect to such advisory vote.

 

Votes For      Votes Against      Abstentions      Broker
Non-Votes*
 
  188,934,562         13,836,359         2,481,413         19,163,759   

 

* Broker non-votes represent shares held by broker nominees for beneficial owners that were not voted with respect to a non-routine proposal because the broker nominee did not receive voting instructions from the beneficial owner and lacked discretionary authority to vote the shares. If a broker does not receive voting instructions from the beneficial owner, a broker may vote on routine matters but may not vote on non-routine matters. Broker non-votes are counted for the purpose of determining the presence of a quorum but are not counted for the purpose of determining the number of shares entitled to vote on non-routine matters such as an election of directors and the advisory vote on the Company’s named executive officer compensation.


  3. Stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2012. The table below summarizes the number of shares that voted for, against and abstained from voting for the ratification of the selection of Ernst & Young LLP.

 

Votes For      Votes Against      Abstentions  
  221,370,030         2,999,723         46,340   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    HEALTH MANAGEMENT ASSOCIATES, INC.
Date: May 23, 2012     By:  

/s/ Gary S. Bryant

      Gary S. Bryant
      Vice President and Controller